Prof. Sivagnanam Thamilselvan

Department of Urology

Henry Ford Health System, USA

Senior Scientist

College of Integrated Science and Technology

James Madison University, USA

Associate Professor

Email: [email protected]

Qualifications

1993 Ph.D., University of Madras, India, Medical Biochemistry

1988 M.Phil., University of Madras, India, Medical Biochemistry

1987 M.Sc., University of Madras, India, Medical Biochemistry

1983 B.Sc., Loyola College, India, Zoology

Publications (Selected)

1. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2017). In vitro and in vivo effect of carmustine and selenite combination on EGFR signaling in androgen-independent prostate cancer. Cancer Research, 77(13_Supplement), 2036-2036.
2. Thamilselvan, V., Menon, M., Stein, G. S., Valeriote, F., & Thamilselvan, S. (2017). Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen‐Independent Prostate Cancer Cells. Journal of cellular biochemistry, 118(12), 4331-4340.
3. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2016). Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor‐variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer. International journal of cancer, 139(7), 1632-1647.
4. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2015). Abstract LB-A18: Combination therapy of carmustine and selenite targets AR full length and AR variants: New hope for patients with castration resistant prostate cancer. Molecular Cancer Therapeutics, 14(12_Supplement_2), LB-A18.
5. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2015). MP46-20 CARMUSTINE AND SELENITE COMBINATION THERAPY EFFECTIVELY INHIBITS CASTRATION RESISTANT PROSTATE CANCER IN PRECLINICAL MODELS. The Journal of Urology, 193(4S), e551-e551.
6. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2014). mp20-14 uncoupled endothelial nitric oxide synthase contributes to oxalate-induced oxidative cell injury in renal epithelial cells: effect of antioxidants. The Journal of Urology, 191(4S), e201-e201.
7. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2014). Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of α‐tocopherol and ascorbic acid. BJU international, 114(1), 140-150.
8. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2013). 2086 Oxalate-induced nadph oxidase activation in renal epithelial cells: role of upstream mediators. The Journal of Urology, 189(4S), e856-e856.
9. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2012). Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells. Cancer Management and Research, 383-395.
10. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2012). 2072 ROLE OF REACTIVE OXYGEN SPECIES AND CARDIOLIPIN PEROXIDATION IN OXALATE-INDUCED RENAL MITOCHONDRIAL DYSFUNCTION: EFFECT OF ANTIOXIDANTS. The Journal of Urology, 187(4S), e835-e836.
11. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2011). Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase‐3 β/β‐catenin pathway. International journal of cancer, 129(12), 2916-2927.
12. Thamilselvan, V., Menon, M., & Thamilselvan, S. (2012). Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury. Urological research, 40, 415-423.

Profile Details

https://orcid.org/0000-0001-9821-5760

https://www.researchgate.net/profile/Sivagnanam-Thamilselvan